舒普深与头孢哌酮治疗小儿肺炎疗效对比

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:djsfhkjthrekl
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的对比舒普深与头孢哌酮治疗小儿肺炎的临床疗效。方法 64例小儿肺炎患儿,随机分为治疗组与对照组,各32例。治疗组患儿给予舒普深进行治疗,对照组患儿给予头孢哌酮治疗,对比两组的临床疗效。结果治疗组总有效率为96.9%,对照组总有效率为81.3%,治疗组疗效明显优于对照组,差异具有统计学意义(P<0.05);治疗组症状及体征改善情况明显优于对照组,差异具有统计学意义(P<0.05)。结论舒普深与头孢哌酮治疗小儿肺炎相比,舒普深的临床效果快,患儿症状、体征改善情况也优于头孢哌酮。 Objective To compare the clinical effects of Shu Pu Shen and cefoperazone in the treatment of children with pneumonia. Methods 64 cases of children with pneumonia were randomly divided into treatment group and control group, 32 cases each. Patients in the treatment group were treated with Shu Pu Shen, patients in the control group were treated with cefoperazone, and the clinical efficacy was compared between the two groups. Results The total effective rate was 96.9% in the treatment group and 81.3% in the control group. The curative effect in the treatment group was significantly better than that in the control group (P <0.05). The symptoms and signs in the treatment group were better than those in the control group Group, the difference was statistically significant (P <0.05). Conclusion Shu Pushen compared with cefoperazone treatment of children with pneumonia, Shu deep deep clinical results, children with symptoms and signs of improvement than cefoperazone.
其他文献
期刊
期刊
期刊
目的了解锦州地区住院患者梅毒感染状况,预防梅毒医源性感染。方法采用梅毒血清凝集试验和甲苯胺红试验方法,对辽宁医学院附属第三医院2008-2012年期间住院患者送检标本进行
期刊
@@
期刊
在临床治疗中,伴随PCI技术使用范围的不断推广,以及从该技术中病情获得稳定的病例数持续增加,我国卫计委要求介入手术一定要严格地执行标准体系。目前,本院介入治疗技术和医疗器
目的建立耐甲氧西林金黄色葡萄球菌(MRSA)医院感染干预措施,有效控制其感染在临床传播。方法采用回顾性调查方法,对一所中医医院风湿病科住院患者耐甲氧西林金黄色葡萄球菌医
期刊
@@
期刊
近年来老年患者呈明显增多趋势,其中多数病史较长,同时伴有一种或多种基础疾病,在手术操作和围手术期处理方面均存在风险.由于观念问题喀什地区择期手术较少,多数为急症就诊.
期刊